← Eichor
Study identifier: NCT05519332 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Percutaneous Vertebral-disc Plasty for Thoracolumbar Very Severe Osteoporotic Vertebral Compression Fractures

Condition: Osteoporotic Fracture of Vertebra  ·  Sponsor: Jiawei Jiang

PhaseNA
Planned participants100
Who can joinAll sexes, 58 Years to 84 Years
Healthy volunteersNo

About this study

Purpose: To compare the clinical outcomes and radiological parameters of patients undergoing percutaneous vertebroplasty (PVP) versus those undergoing percutaneous vertebral-disc plasty (PVDP) for back pain, segmental instability, and kyphosis due to thoracolumbar very severe osteoporotic vertebral compression fractures (vsOVCFs). This prospective study included elderly patients with thoracolumbar vsOVCFs. All the patients were randomly allocated into the PVP group (who underwent conventional PVP) and the PVDP group (who underwent PVP combined percutaneous cement discoplasty). The visual analogue scale (VAS), Oswestry Disability Index (ODI), local kyphosis angle, and disc height were recorded preoperatively and postoperatively.

This description comes directly from the study's public registry record.

Talk to the study team

Jiawei Jiang, Dr  ·  18862802782  ·  18862802782@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Affiliated 2 Hospital of Nantong UniversityNantong, Jiangsu, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05519332